A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs. Researchers have developed a novel compound, MDV3100, which blocks the androgen receptor in CRPC cells, lowering PSA levels and reducing tumor growth.
Researchers found no correlation between aggressive treatment and improved survival rates for early stage bladder cancer patients. Aggressively treated patients were more likely to undergo major surgery, resulting in higher treatment costs.
The American Institute of Ultrasound in Medicine (AIUM) has recognized Fred Winsberg, Martin Resnick, and Horace Thompson as pioneers in the field of ultrasound in medicine. Drs. Winsberg and Resnick were renowned experts in radiology and urology, respectively, while Dr. Thompson is considered the
Researchers have found that sarcosine distinguishes between slow-growing and aggressive prostate cancers. The metabolomic analysis suggests that sarcosine is highly associated with tumour development and can predict the aggressiveness of tumors.
Researchers are developing new classes of anti-androgen therapies, including MDV3100, abiraterone, and OGX-427, to treat castrate-resistant prostate cancer (CRPC). Angiogenesis inhibitors like bevacizumab target vascular endothelial growth factor (VEGF) to slow tumor growth and metastasis.
The SPCG-4 trial found that radical prostatectomy significantly reduces prostate cancer mortality and risk of metastases, with little to no increase in benefits over a 12-year follow-up. The study suggests that well-structured pre-treatment information, patient understanding, and support are crucial for managing prostate cancer.
The study found that PSA screening can reduce prostate cancer deaths by 20%, saving one life for every 1,408 men screened. The European Association of Urology's largest prostate cancer screening study provides robust evidence for the effectiveness of screening on prostate cancer mortality.
Researchers found that collagen injections can improve symptoms of stress urinary incontinence (SUI) in some patients, even after surgical treatment fails. The procedure involves injecting collagen into the tissue surrounding the urethra to tighten the sphincter and prevent leakage.
The European Association of Urology has released new clinical guidelines for kidney cancer treatment, emphasizing the use of targeted agents and nephron-sparing surgery. The guidelines recommend first-line therapies for low- and intermediate-risk patients, as well as second-line options for high-risk patients.
A multi-center study recommends that men diagnosed with low-risk prostate cancer can safely choose observation over immediate treatment, closely monitored. This approach is associated with a low risk of metastatic spread and is not a total disregard for patients with prostate cancer.
A team of Columbia University researchers has identified a new investigational therapy for bladder cancer, inhibiting the mTOR signaling pathway with rapamycin. The discovery demonstrates that p53 and PTEN tumor suppressor genes are inactivated in invasive bladder cancer.
Researchers at the University of Michigan have identified a potential new biomarker, sarcosine, that can distinguish between aggressive and non-aggressive prostate cancers. Sarcosine levels in urine may help predict cancer aggressiveness and identify patients who need aggressive treatment.
Researchers identified proepithelin as a protein that encourages cell growth and migration in prostate cancer cells, especially androgen-independent ones. Proepithelin overexpression may serve as a clinical marker for prostate cancer diagnosis and a therapeutic target.
A Johns Hopkins study found that older men with PSA levels less than 3 nanograms per milliliter are unlikely to die of or experience aggressive prostate cancer. This suggests that routine PSA testing may be unnecessary for some older men, potentially reducing costs and morbidity.
Research suggests that discontinuing routine PSA screening in elderly men (75+ years old) with low PSA levels may not increase undetected lethal disease rates. Instead, it could avoid unnecessary treatments and reduce diagnostic costs. Men over 75 with PSA < 3ng/ml have a low risk of developing high-risk prostate cancer.
A study by researchers at UCSF found that behavioral weight-loss programs can significantly reduce urinary incontinence in overweight and obese women. Participants who lost an average of 17 pounds experienced a 47% reduction in incontinence episodes compared to those in the control group.
Researchers have discovered a novel way in which the Myc oncogene accelerates cancer by directly affecting protein production, suggesting a new strategy to halt cancer's progression. Drugs like Rapamycin may help treat cancers where Myc is overactive.
Researchers developed nomograms to predict long-term kidney transplant success and refine patient selection for living donor transplants. The models analyzed over 20,000 cases and identified key donor and recipient characteristics impacting transplant outcomes.
Researchers investigate thalidomide for biochemical recurrence and adjuvant radiotherapy for improved survival, reducing metastases risk by 29%. Both treatment options show promise for patients with biochemically recurrent prostate cancer after surgery.
Researchers at Northwestern University have successfully designed synthetic HDL, a nanoparticle version capable of irreversibly binding cholesterol. The study shows that the synthetic HDL mimics natural HDL's surface composition and could one day help fill the gap in useful therapeutics for raising good cholesterol.
Scientists at Stanford University School of Medicine and UC-San Francisco have successfully isolated stem cells from human testes, which can differentiate into various types of tissues. The findings suggest that these cells are not as pluripotent as embryonic stem cells but have unique therapeutic applications.
A UCLA study found that low-income men are more likely to present with advanced prostate cancers, highlighting the need for increased access to screening services. The study also revealed that diagnosis rates for lower-risk cancers did not increase over time among IMPACT patients, unlike in more affluent populations.
A recent study published in The Journal of Urology found that low-income men are diagnosed with more advanced prostate cancer due to inadequate access to screening services. This disparity is significant, as the study reveals that 19% of these men were diagnosed with metastatic cancer, compared to 4% in the general population.
The study found that the majority of men complied with PSA and DRE tests, with over 84% of diagnosed cancers picked up by screening. Cancer detected at baseline tended to be more serious and aggressive than those detected later.
The International Society of Andrology, European Association of Urology, and other scientific organizations have formulated new recommendations on late-onset hypogonadism (LOH) treatment. These guidelines emphasize the importance of addressing symptoms such as erectile dysfunction and low testosterone levels in aging men.
A new prostate cancer drug, degarelix, has been shown to dramatically reduce testosterone levels in patients as early as three days after treatment. Compared to other treatments, degarelix also resulted in faster declines in prostate-specific antigen (PSA) levels and fewer side effects such as urinary tract infections and joint pains.
Researchers from Baylor College of Medicine found that prostate cancer promotes the growth of new nerves and axons, a phenomenon associated with more aggressive tumors. This discovery could lead to new targets for treatment, as neurogenesis is present in more aggressive cancers.
Surgeons at the University of Chicago Medical Center have successfully performed the world's first pediatric robotic bladder reconstruction, using the DaVinci system. The innovative technique resulted in good outcomes and minimal complications, with the patient regaining full control over her bladder after six weeks.
A new at-home test, SpermCheck Vasectomy, has been shown to accurately detect low sperm counts in vasectomized men. The test achieved an accuracy rate of 96% in identifying sperm concentrations below a threshold of 250,000 sperm per ml.
A recent study published in European Urology found a significant relationship between prostate inflammation and lower urinary tract symptoms (LUTS) in men. The study, which analyzed data from the REDUCE trial, revealed that chronic inflammation was associated with higher IPSS scores and a greater degree of LUTS.
The HPV-positive cancer cells adapted to the hypoxic environment by expressing a protein that activates a cell signaling pathway, helping them survive, grow and spread. The study may lead to new therapies targeting this pathway to interrupt cancer cell proliferation.
A landmark UCLA study reveals that tailored treatment approaches can significantly improve kidney cancer patient survival rates, with some patients experiencing excellent outcomes of up to 97%. The study identified subsets of patients who require different levels of treatment, including surgery and targeted therapies.
Popular cholesterol-busting drugs statins appear to lower men's PSA values along with their cholesterol levels. However, it remains unclear whether statins prevent prostate cancer growth or just mask it. The study found that PSA levels declined by an average of about four percent after starting statins.
A new prostate cancer gene test using a urine sample has shown promising results in detecting the disease at an early stage. The test, PCA3, is highly specific to PCa and may allow patients to avoid unnecessary biopsies.
A multi-centre study of 863 patients from 14 countries found that solifenacin significantly improved overactive bladder symptoms, with a 70% reduction in severe urgency and urgency incontinence. Patients reported reduced urine frequency and fewer incontinence episodes within three days.
Researchers at Northwestern University believe spicy food, including pepperoni pizza, can worsen pelvic pain and urinary frequency in women with interstitial cystitis. A new treatment approach using anesthetic patches or suppositories may provide relief.
A study of 1,500 kidney cancer patients suggests that tissue-sparing surgery may improve overall survival in patients with reduced kidney function. The finding highlights the underuse of this option and raises concerns about the potential harm of removing healthy kidney tissue.
University of Iowa researchers are investigating the roles of the pituitary gland and sympathetic nervous system in interstitial cystitis inflammation. The study aims to identify potential causes of the painful bladder condition, which affects over 1 million Americans.
The American Urological Association has released a best practice statement on cryosurgery, recommending it as an option for men with clinically organ-confined prostate cancer. The panel of experts emphasized the importance of case selection and recommended maximizing results through temperature monitoring and double freeze cycles.
Researchers found that genetic programs forming the prostate in embryos are similar to those driving tumor growth in prostate cancers. They identified genes involved in cell survival, growth, and movement that are activated in both normal development and aggressive prostate cancers.
Common painkillers such as aspirin and ibuprofen appear to lower a man's PSA level, the blood biomarker used to gauge prostate cancer risk. However, the study does not prove a direct link between the medications and reduced risk of prostate cancer.
The UK government's 'bare below the elbows' rule for doctors is aimed at reducing hospital-acquired infections like MRSA and C.difficile. However, medical opinion is divided on whether this policy will compromise professional image without sufficient evidence of infection reduction.
A paper on stress urinary incontinence treatment has been retracted from publication after an investigation found critical deficiencies in patient consent and document authenticity. Senior author Georg Bartsch denied involvement, but the study's flaws have raised concerns about research integrity.
A study from Columbia University's Mailman School of Public Health found associations between smoking, obesity, and physical inactivity with lower Prostate Specific Antigen (PSA) awareness. This may lead to reduced prostate cancer screening rates among affected individuals.
A study published in European Urology found that vardenafil, a PDE5 inhibitor, is more efficacious when used on-demand in men with erectile dysfunction following bilateral nerve-sparing radical prostatectomy. On-demand use of vardenafil was associated with significantly greater erectile function and sexual intercourse completion rates ...
A new study published in European Urology found that patients who underwent robot-assisted laparoscopic radical prostatectomy experienced higher levels of dissatisfaction and regret, particularly African-American patients. Longer follow-up periods were also associated with increased regret.
A new study published in The Journal of Urology found that tadalafil improved lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH). Daily dosing of the erectile dysfunction drug showed clinically meaningful improvements, making it a suitable option for treating BPH LUTS.
A team of urologists has successfully used robot-assisted laparoscopic surgery to repair abnormal openings between the bladder and vagina, known as fistulas. The procedure resulted in less blood loss and faster recovery times compared to traditional abdominal surgery, offering a promising alternative for women with this condition.
A study published by researchers at Duke University Medical Center found that only one-fifth of men under age 50 reported undergoing a PSA test in the previous year. Black men and men with a family history are disproportionately affected, highlighting the need for increased awareness and screening efforts.
Research finds that PSA screening can lead to delayed diagnosis and more aggressive cancer outcomes for obese men. The study suggests that alternative screening methods or lower threshold for worrisome PSA levels may be necessary for this population.
Research shows Vietnam War veterans exposed to Agent Orange have increased risks of prostate cancer and aggressive forms of the disease compared to those not exposed. The study, conducted on over 13,000 men in their 60s, found twice as many exposed veterans developed prostate cancer.
A new study reveals significant variations in prostate cancer care quality by region, hospital type, and race, suggesting areas for improvement to enhance patient outcomes. Compliance rates with standardized measures vary greatly among healthcare facilities, highlighting the need for standardization.
The European Urology journal has released its new impact factor of 5.634, highlighting the journal's outstanding quality and international profile. This achievement is directly related to the success of the European Association of Urology (EAU), which represents over 16,000 urologists across Europe and worldwide.
Researchers at UT Southwestern Medical Center predict that global warming will cause a 30% growth in kidney-stone cases by 2050, with an additional 1.6-2.2 million new cases. Dehydration is a major risk factor for kidney stones, and warmer temperatures are expected to exacerbate this effect.
Using an engineered virus, UCLA researchers locate prostate cancer cells in the pelvic lymph nodes, where it spreads first before invading other organs. The discovery may lead to more effective diagnostic and therapeutic approaches for advanced prostate cancer.
A new study from the University of Michigan Comprehensive Cancer Center finds that more than three-quarters of bladder cancer patients are unaware of the link between smoking and bladder cancer. Quitting smoking can decrease the risk of developing bladder cancer by 40% within four years.
Regular cycling can cause genital numbness, erection problems and skin irritations in men. Choosing the right bike is essential to prevent these health issues, including ensuring proper saddle fit, pedal resistance and padding.
A panel of seven biomarkers can predict prostate cancer risk with high accuracy, offering a major step forward in patient care. Elevated levels of these biomarkers were associated with increased risk of relapse, and the combination of all seven variables accurately predicted risk 86.6 percent of the time.
Researchers found that female mice who became pregnant had significantly fewer bladder cancers than their counterparts, with an average tumor volume about 15 times greater in non-pregnant females. The study suggests a possible role for hormones in bladder cancer protection.
Researchers at UT Southwestern Medical Center have identified a panel of seven biomarkers that can predict prostate cancer recurrence with 86 percent accuracy. This finding holds promise for personalized medicine and targeted therapy, potentially improving treatment outcomes and patient care.